Bibliographie
1.
Sardanelli F, Boetes C, Borisch B et al. Magnetic resonance imaging of the breast: recommendations
from the EUSOMA working group. Eur J Cancer. 2010 May;46(8):1296-316.
2.
Lacambra M, Lam C, Mendoza P et al. Biospy sampling of breast lesions : comparison of core needle
and vacuum assisted breast biopsies. Breast Cancer Res Treat 2012;132:917-23
3.
INCa. © Cancer du sein infiltrant non métastatique - Questions d'actualités - Rapport intégral.
Collection Avis & Recommandations, INCa, Boulogne-Billancourt, juillet 2012
4.
Houssami N, Ciatto S, Tyrner R et al. Preoperative ultrasound guided needle biopsy of axillary nodes in
invasive breast cancer. Meta-analysis of its accuracy and utility in staging the axilla. Annals of surgery
2011; 254(2):243-51.
5.
Uematsu T, Kasami M et Yuen S. Neoadjuvant chemotheray for breast cancer : correlation between the
baseline MR imaging findinds and responses t thérapy. Eur Radiol 2010 20 (10): 2315-22.
6.
t al. Diffusion-weighted MR imaging: pretreatment prediction of
response to neoadjuvant chemotherapy in patients with breast cancer
010;257(1):56-63.
7.
El Khoury C, Servois V, Thibault F et al. MR quantification of washout changes in breast tumors under
preoperative chemotherapy :feasibility and preliminary results. AJR 2005;184:1499-04
8.
t al. DW-MRI ADC values can predict treatment response in patients with
locally advanced breast cancer undergoing neoadjuvant chemotherapy
2012;29(2):425-31.
9.
Wu LM, Hu JN, Gu HY et al.Can diffusion weighted MRI and contrast enhanced MRI precisely
evaluate and predict pathological response ton NAC in patients with breast cancer? Breast Cancer Res
Treat 2012;135:17-28.
10.
Lai HW, Dar-Ren C, Yao-Chung W et al. Comparison of the diagnostic accuracy of MRI with
sonography in the prediction of Breats tumor size. An n Surg Oncol 2015;22(2):3816-23
11.
Brennan ME, Houssami N
Breast. 2012 21(2):112-23
12.
Pickles MD, Manton DJ, Lowry M, Turnbull LW. Prognostic value of pre-treatment DCE-MRI
parameters in predicting disease free and overall survival for breast cancer patients undergoing
neoadjuvant chemotherapy. Eur J Radiol. 2009;71(3):498-505
13.
Li S, Makris A, Beresford M et al. Use of DCE-MRI to predict survival in patients with primary breast
cancer undergoing CAN. Radiology 2011; 260: 68- 77
14.
Kaufmann M, VonMinckwitz, Mamounas E et al. Recommendations from an international consensus
conférence on the current status and future of neoadjuvant systemic thérapy in primary breast cancer.
Ann Surg Oncol 2012;19:1508-1516.
